Manufacturer
Janssen (Johnson & Johnson) NDC Codes
Finished products listed with the FDA under labeler names that contain “Janssen”.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Stelaraustekinumab | Ustekinumab 45 mg/.5mL | Injection, SolutionSubcutaneous | Janssen Biotech, Inc. | 57894-060 |
| Stelaraustekinumab | Ustekinumab 90 mg/mL | Injection, SolutionSubcutaneous | Janssen Biotech, Inc. | 57894-061 |
| Symtuzadarunavir, cobicistat, emtricitabine, and tenofovir alafenamide | Darunavir 800 mg/1 + 3 more ingredients | Tablet, Film coatedOral | Janssen Products LP | 59676-800 |
| Talveytalquetamab | Talquetamab 3 mg/1.5mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-469 |
| Talveytalquetamab | Talquetamab 40 mg/mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-470 |
| Tecvayliteclistamab-cqyv | Teclistamab 10 mg/mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-449 |
| Tecvayliteclistamab-cqyv | Teclistamab 90 mg/mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-450 |
| Topamaxtopiramate | Topiramate 25 mg/1 | Tablet, CoatedOral | Janssen Pharmaceuticals, Inc. | 50458-639 |
| Topamaxtopiramate | Topiramate 50 mg/1 | Tablet, CoatedOral | Janssen Pharmaceuticals, Inc. | 50458-640 |
| Topamaxtopiramate | Topiramate 100 mg/1 | Tablet, CoatedOral | Janssen Pharmaceuticals, Inc. | 50458-641 |
| Topamaxtopiramate | Topiramate 200 mg/1 | Tablet, CoatedOral | Janssen Pharmaceuticals, Inc. | 50458-642 |
| Topamaxtopiramate | Topiramate 25 mg/1 | Capsule, Coated pelletsOral | Janssen Pharmaceuticals, Inc. | 50458-645 |
| Topamaxtopiramate | Topiramate 15 mg/1 | Capsule, Coated pelletsOral | Janssen Pharmaceuticals, Inc. | 50458-647 |
| Tremfyaguselkumab | Guselkumab 100 mg/mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-640 |
| Tremfyaguselkumab | Guselkumab 200 mg/20mL | InjectionIntravenous | Janssen Biotech, Inc. | 57894-650 |
| Tremfyaguselkumab | Guselkumab 200 mg/2mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-651 |
| ustekinumab | Ustekinumab 45 mg/.5mL | Injection, SolutionSubcutaneous | Janssen Biotech, Inc. | 57894-440 |
| ustekinumab | Ustekinumab 90 mg/mL | Injection, SolutionSubcutaneous | Janssen Biotech, Inc. | 57894-441 |
| ustekinumab | Ustekinumab 130 mg/26mL | SolutionIntravenous | Janssen Biotech, Inc. | 57894-444 |
| Vermoxmebendazole | Mebendazole 500 mg/1 | Tablet, ChewableOral | Janssen Pharmaceuticals, Inc. | 50458-675 |
| Xareltorivaroxaban | Rivaroxaban 155 mg/1 | Granule, For suspensionOral | Janssen Pharmaceuticals, Inc. | 50458-575 |
| Xareltorivaroxaban | Rivaroxaban 2.5 mg/1 | Tablet, Film coatedOral | Janssen Pharmaceuticals, Inc. | 50458-577 |
| Xareltorivaroxaban | Rivaroxaban 15 mg/1 | Tablet, Film coatedOral | Janssen Pharmaceuticals, Inc. | 50458-578 |
| Xareltorivaroxaban | Rivaroxaban 20 mg/1 | Tablet, Film coatedOral | Janssen Pharmaceuticals, Inc. | 50458-579 |
| Xareltorivaroxaban | Rivaroxaban 10 mg/1 | Tablet, Film coatedOral | Janssen Pharmaceuticals, Inc. | 50458-580 |